Page 59 - Amgen News Today

Amgen (NASDAQ:AMGN – Get Free Report) had its price objective lifted by investment analysts at UBS Group from $284.00 to $307.00 in a research report issued to clients and investors on Friday, Benzinga reports. The brokerage currently has a “neutral” rating on the medical research company’s stock. UBS Group’s price target would suggest a potential […]

BioPharma

Health-care companies rose after a surprising new entrant in the obesity-drug bonanza from one biotech giant. Amgen shares surged after the biotech giant said it saw encouraging signs from its... -May 03, 2024 at 05:06 pm EDT - MarketScreener

Competition is heating up in the GLP-1 space as Amgen gets closer to the finish line with its candidate.

Equities finished the week in fine style in Toronto, though the gains seen on Friday indexes did not quite make up for negative readings throughout the rest of the week. The TSX Composite stayed higher 124.19 points to close Friday at 21,947.41. ...

Stocks closed sharply higher on Wall Street, erasing their losses for the week, after the government reported a cooldown in hiring last month. For markets that was a welcome sign

Stocks closed sharply higher on Wall Street, erasing their losses for the week, after the government reported a cooldown in hiring last month. For markets that was a welcome sign

Stocks closed sharply higher on Wall Street, erasing their losses for the week, after the government reported a cooldown in hiring last month. For markets that was a welcome sign

Stocks closed sharply higher on Wall Street, erasing their losses for the week, after the government reported a cooldown in hiring last month. For markets that was a welcome sign

Stocks closed sharply higher on Wall Street, erasing their losses for the week, after the government reported a cooldown in hiring last month. For markets that was a welcome sign